Skip to main content

Advertisement

Log in

Pathogenesis of HIV and the Lung

  • HIV Pathogenesis and Treatment (A Landay, Section Editor)
  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Antiretroviral therapy has improved longevity for HIV-infected persons, but long-term HIV infection is now complicated by increased rates of chronic medical conditions including pulmonary disorders. Chronic obstructive pulmonary disease, lung cancer, asthma, and pulmonary hypertension are becoming common comorbidities of HIV infection, and these diseases may develop as a result of HIV-related risk factors, such as antiretroviral drug toxicities, colonization by infectious organisms, HIV viremia, immune activation, or immune dysfunction. It also appears that the ability to control HIV infection does not completely eliminate the risk for infectious complications, such as bacterial pneumonia and tuberculosis. The effect of HIV infection on lung-specific immune responses is being elucidated to help develop better prevention and treatment strategies in HIV-infected persons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Murray JF, Felton CP, Garay SM, Gottlieb MS, Hopewell PC, Stover DE, et al. Pulmonary complications of the Acquired Immunodeficiency Syndrome. Report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med. 1984;310:1682–8.

    Article  PubMed  CAS  Google Scholar 

  2. Murray JF, Garay SM, Hopewell PC, Mills J, Snider GL, Stover DE. NHLBI workshop summary. Pulmonary complications of the Acquired Immunodeficiency Syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis. 1987;135:504–9.

    PubMed  CAS  Google Scholar 

  3. •• Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez-Barradas MC, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011;183:388–95. A study of 33,420 HIV-infected veterans and 66,840 HIV-uninfected veterans matched by age, sex, race, and ethnicity, and site that demonstrated that HIV infection was associated with increased incidence of COPD, lung cancer, pulmonary hypertension, lung fibrosis, tuberculosis, bacterial pneumonia, and Pneumocystis pneumonia.

    Article  PubMed  Google Scholar 

  4. Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Nagaraja HN, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med. 2000;132:369–72.

    PubMed  CAS  Google Scholar 

  5. Morris AM, Huang L, Bacchetti P, Turner J, Hopewell PC, Wallace JM, et al. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 2000;162(2 Pt 1):612–6.

    PubMed  CAS  Google Scholar 

  6. Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994–1998. J Infect Dis. 2002;186:1023–7.

    Article  PubMed  Google Scholar 

  7. Drummond MB, Kirk GD, Astemborski J, Marshall MM, Mehta SH, McDyer JF, et al. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax. 2012;67:309–14.

    Article  PubMed  Google Scholar 

  8. George MP, Kannass M, Huang L, Sciurba FC, Morris A. Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One. 2009;4:e6328.

    Article  PubMed  Google Scholar 

  9. • Gingo MR, George MP, Kessinger CJ, Lucht L, Rissler B, Weinman R, et al. Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med. 2010;182:790–6. Demonstrated a high prevalence of irreversible airflow obstruction and abnormal pulmonary diffusing capacity even in never-smokers. Supported prior finding that airflow obstruction was associated with ART use.

    Article  PubMed  Google Scholar 

  10. Hirani A, Cavallazzi R, Vasu T, Pachinburavan M, Kraft WK, Leiby B, et al. Prevalence of obstructive lung disease in HIV population: a cross-sectional study. Respir Med. 2011;105:1655–61.

    Article  PubMed  Google Scholar 

  11. Kristoffersen US, Lebech AM, Mortensen J, Gerstoft J, Gutte H, Kjaer A. Changes in lung function of HIV-infected patients: a 4.5-year follow-up study. Clin Physiol Funct Imaging. 2012;32:288–95.

    Article  PubMed  Google Scholar 

  12. Crothers K, Kleerup EC, Wongtrakool C, Soo Hoo G, Kim J, Sharafkhaneh A, et al. HIV infection is associated with impaired pulmonary diffusing capacity. [abstract #819] Presented at the 19th Conference on retroviruses and oppurtunistic infections. Seattle, Washington. March 5–8, 2012.

  13. Crothers K, Huang L. Pulmonary complications of immune reconstitution inflammatory syndromes in HIV-infected patients. Respirology. 2009;14:486–94.

    Article  PubMed  Google Scholar 

  14. Mori S, Levin P. A brief review of potential mechanisms of immune reconstitution inflammatory syndrome in HIV following antiretroviral therapy. Int J STD AIDS. 2009;20:447–52.

    Article  PubMed  CAS  Google Scholar 

  15. Morris A, Alexander T, Radhi S, Lucht L, Sciurba FC, Kolls JK, et al. Airway obstruction is increased in Pneumocystis-colonized human immunodeficiency virus-infected outpatients. J Clin Microbiol. 2009;47:3773–6.

    Article  PubMed  Google Scholar 

  16. Kling HM, Shipley TW, Patil SP, Kristoff J, Bryan M, Montelaro RC, et al. Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection. Infect Immun. 2010;78:4320–30.

    Article  PubMed  CAS  Google Scholar 

  17. • Shipley TW, Kling HM, Morris A, Patil S, Kristoff J, Guyach SE, et al. Persistent Pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. J Infect Dis. 2010;202:302–12. Demonstrates in a non-human primate model that colonization with Pneumocystis leads to airflow obstruction and emphysematous changes in the lung. This study supports Pneumocystis colonization as a causative agent for chronic obstructive pulmonary disease, which has therapeutic implications for chronic obstructive pulmonary disease in humans.

    Article  PubMed  CAS  Google Scholar 

  18. Christensen PJ, Preston AM, Ling T, Du M, Fields WB, Curtis JL, et al. Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice. Infect Immun. 2008;76:3481–90.

    Article  PubMed  CAS  Google Scholar 

  19. Morris A, George MP, Crothers K, Huang L, Lucht L, Kessinger C, et al. HIV and chronic obstructive pulmonary disease: is it worse and why? Proc Am Thorac Soc. 2011;8:320–5.

    Article  PubMed  Google Scholar 

  20. Poirier CD, Inhaber N, Lalonde RG, Ernst P. Prevalence of bronchial hyperresponsiveness among HIV-infected men. Am J Respir Crit Care Med. 2001;164:542–5.

    PubMed  CAS  Google Scholar 

  21. Wallace JM, Stone GS, Browdy BL, Tashkin DP, Hopewell PC, Glassroth J, et al. Nonspecific airway hyperresponsiveness in HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest. 1997;111:121–7.

    Article  PubMed  CAS  Google Scholar 

  22. Cui Q, Carruthers S, McIvor A, Smaill F, Thabane L, Smieja M. Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study. AIDS Res Ther. 2010;7:6.

    Article  PubMed  Google Scholar 

  23. • Gingo MR, Wenzel SE, Steele C, Kessinger CJ, Lucht L, Lawther T, et al. Asthma diagnosis and airway bronchodilator response in HIV-infected patients. J Allergy Clin Immunol. 2012;129:708–14 e8. First study to report on asthma diagnosis and bronchodilator response and potential mechanisms in HIV-infected persons during the effective ART era.

    Article  PubMed  Google Scholar 

  24. Bridevaux PO, Probst-Hensch NM, Schindler C, Curjuric I, Felber Dietrich D, Braendli O, et al. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J. 2010;36:1259–69.

    Article  PubMed  Google Scholar 

  25. Appleton SL, Adams RJ, Wilson DH, Taylor AW, Ruffin RE. Spirometric criteria for asthma: adding further evidence to the debate. J Allergy Clin Immunol. 2005;116:976–82.

    Article  PubMed  Google Scholar 

  26. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 1995;270:1811–5.

    Article  PubMed  CAS  Google Scholar 

  27. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52:611–22.

    Article  PubMed  Google Scholar 

  28. Engsig FN, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, et al. Lung cancer in HIV patients and their parents: a Danish cohort study. BMC Cancer. 2011;11:272.

    Article  PubMed  Google Scholar 

  29. Sigel K, Wisnivesky J, Gordon K, Dubrow R, Justice A, Brown ST, et al. HIV as an independent risk factor for incident lung cancer. AIDS. 2012;26(8):1017–25.

    Article  PubMed  Google Scholar 

  30. Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009;23:2337–45.

    Article  PubMed  Google Scholar 

  31. Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:2551–9.

    Article  PubMed  CAS  Google Scholar 

  32. Levine AM, Seaberg EC, Hessol NA, Preston-Martin S, Silver S, Cohen MH, et al. HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol. 2010;28:1514–9.

    Article  PubMed  Google Scholar 

  33. Seaberg EC, Wiley D, Martinez-Maza O, Chmiel JS, Kingsley L, Tang Y, et al. Cancer incidence in the Multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer. 2010;116:5507–16.

    Article  PubMed  Google Scholar 

  34. Shiels MS, Cole SR, Mehta SH, Kirk GD. Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr. 2010;55:510–5.

    Article  PubMed  Google Scholar 

  35. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001;410:1107–11.

    Article  PubMed  CAS  Google Scholar 

  36. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009;100:840–7.

    Article  PubMed  CAS  Google Scholar 

  37. D'Jaen GA, Pantanowitz L, Bower M, Buskin S, Neil N, Greco EM, et al. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer. 2010;11:396–404.

    Article  PubMed  Google Scholar 

  38. Clifford GM, Lise M, Franceschi S, Egger M, Bouchardy C, Korol D, et al. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer. 2012;106:447–52.

    Article  PubMed  CAS  Google Scholar 

  39. Simard EP, Pfeiffer RM, Engels EA. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer. 2011;117:1089–96.

    Article  PubMed  Google Scholar 

  40. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103:753–62.

    Article  PubMed  Google Scholar 

  41. Lee JY, Moore PC, Lensing SY. Impact of HIV infection on medicare beneficiaries with lung cancer. J Cancer Epidemiol. 2012;2012:706469.

    PubMed  Google Scholar 

  42. Makinson A, Tenon JC, Eymard-Duvernay S, Pujol JL, Allavena C, Cuzin L, et al. Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study. J Thorac Oncol. 2011;6:1022–9.

    Article  PubMed  Google Scholar 

  43. Lavole A, Chouaid C, Baudrin L, Wislez M, Raguin G, Pialoux G, et al. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. Lung Cancer. 2009;65:345–50.

    Article  PubMed  Google Scholar 

  44. Pakkala S, Chen Z, Rimland D, Owonikoko TK, Gunthel C, Brandes JR, et al. Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy. Cancer. 2012;118:164–72.

    Article  PubMed  Google Scholar 

  45. Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension in HIV infection. Chest. 1991;100:1268–71.

    Article  PubMed  CAS  Google Scholar 

  46. Mondy KE, Gottdiener J, Overton ET, Henry K, Bush T, Conley L, et al. High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy. Clin Infect Dis. 2011;52:378–86.

    Article  PubMed  Google Scholar 

  47. Morris A, Gingo MR, George MP, Lucht L, Kessinger C, Singh V, et al. Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era. AIDS. 2012;26:731–40.

    Article  PubMed  Google Scholar 

  48. Hsue PY, Bolger AF, Martin JN. Pulmonary hypertension in HIV-infected individuals. Clin Infect Dis. 2011;53:96. author reply 96–7.

    Article  PubMed  Google Scholar 

  49. Almodovar S, Knight R, Allshouse AA, Roemer S, Lozupone C, McDonald D, et al. Human immunodeficiency virus Nef signature sequences are associated with pulmonary hypertension. AIDS Res Hum Retroviruses. 2012;28:607–18.

    Article  PubMed  CAS  Google Scholar 

  50. Duffy P, Wang X, Lin PH, Yao Q, Chen C. HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. J Surg Res. 2009;156:257–64.

    Article  PubMed  CAS  Google Scholar 

  51. Sehgal PB, Mukhopadhyay S, Patel K, Xu F, Almodovar S, Tuder RM, et al. Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques. Am J Physiol Lung Cell Mol Physiol. 2009;297:L729–37.

    Article  PubMed  CAS  Google Scholar 

  52. Marecki JC, Cool CD, Parr JE, Beckey VE, Luciw PA, Tarantal AF, et al. HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am J Respir Crit Care Med. 2006;174:437–45.

    Article  PubMed  CAS  Google Scholar 

  53. George MP, Brower A, Kling H, Shipley T, Kristoff J, Reinhart TA, et al. Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques. AIDS Res Hum Retroviruses. 2011;27:103–11.

    Article  PubMed  CAS  Google Scholar 

  54. •• Dhillon NK, Li F, Xue B, Tawfik O, Morgello S, Buch S, et al. Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction. Am J Respir Cell Mol Biol. 2011;45:40–52. Identified that cocaine has an additive effect with HIV infection on endothelial dysfunction and pulmonary smooth muscle cell proliferation through disruption of tight junction proteins and increased platelet-derived growth factor expression.

    Article  PubMed  CAS  Google Scholar 

  55. Spikes L, Dalvi P, Tawfik O, Gu H, Voelkel NF, Cheney P, et al. Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine. Am J Respir Crit Care Med. 2012;185:1235–43.

    Article  PubMed  CAS  Google Scholar 

  56. Zuber JP, Calmy A, Evison JM, Hasse B, Schiffer V, Wagels T, et al. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis. 2004;38:1178–85.

    Article  PubMed  Google Scholar 

  57. Opravil M, Pechere M, Speich R, Joller-Jemelka HI, Jenni R, Russi EW, et al. HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med. 1997;155:990–5.

    PubMed  CAS  Google Scholar 

  58. Degano B, Guillaume M, Savale L, Montani D, Jais X, Yaici A, et al. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS. 2010;24:67–75.

    Article  PubMed  Google Scholar 

  59. Steenhoff AP, Josephs JS, Rutstein RM, Gebo KA, Siberry GK, Gaur AH, et al. Incidence of and risk factors for community acquired pneumonia in US HIV-infected children, 2000–2005. AIDS. 2011;25:717–20.

    Article  PubMed  Google Scholar 

  60. Siemieniuk RA, Gregson DB, Gill MJ. The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study. BMC Infect Dis. 2011;11:314.

    Article  PubMed  Google Scholar 

  61. Barbier F, Coquet I, Legriel S, Pavie J, Darmon M, Mayaux J, et al. Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med. 2009;35:1678–86.

    Article  PubMed  Google Scholar 

  62. Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long-term incidence and risk factors in a South African cohort. AIDS. 2005;19:2109–16.

    Article  PubMed  Google Scholar 

  63. Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, Silva G, et al. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995–2001. PLoS One. 2007;2:e826.

    Article  PubMed  Google Scholar 

  64. World Health Organization. Global tuberculosis control 2011. Geneva: WHO; 2011.

    Google Scholar 

  65. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, et al. Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the global project on anti-tuberculosis drug resistance surveillance. Lancet. 2009;373:1861–73.

    Article  PubMed  Google Scholar 

  66. Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet. 2010;375:1798–807.

    Article  PubMed  Google Scholar 

  67. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365:1492–501.

    Article  PubMed  CAS  Google Scholar 

  68. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, et al. Earlier vs later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:1471–81.

    Article  PubMed  CAS  Google Scholar 

  69. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482–91.

    Article  PubMed  CAS  Google Scholar 

  70. Heath L, Fox A, McClure J, Diem K, van 't Wout AB, Zhao H, et al. Evidence for limited genetic compartmentalization of HIV-1 between lung and blood. PLoS One. 2009;4:e6949.

    Article  PubMed  Google Scholar 

  71. Iriart X, Witkowski B, Cassaing S, Abbes S, Menard S, Fillaux J, et al. Alveolar and blood T lymphocyte profiles in Pneumocystis jirovecii-positive patients: effects of HIV status. J Infect Dis. 2011;204:544–53.

    Article  PubMed  Google Scholar 

  72. Jambo KC, Sepako E, Fullerton DG, Mzinza D, Glennie S, Wright AK, et al. Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults. Thorax. 2011;66:375–82.

    Article  PubMed  Google Scholar 

  73. Rubbo PA, Tuaillon E, Bollore K, Foulongne V, Bourdin A, Nagot N, et al. The potential impact of CD4+ T cell activation and enhanced Th1/Th2 cytokine ratio on HIV-1 secretion in the lungs of individuals with advanced AIDS and active pulmonary infection. Clin Immunol. 2011;139:142–54.

    Article  PubMed  CAS  Google Scholar 

  74. Tachado SD, Li X, Bole M, Swan K, Anandaiah A, Patel NR, et al. MyD88-dependent TLR4 signaling is selectively impaired in alveolar macrophages from asymptomatic HIV+ persons. Blood. 2010;115:3606–15.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

M. R. Gingo: grant from NIH/NHLBI; A. Morris: grant from NIH/NHLBI.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alison Morris.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gingo, M.R., Morris, A. Pathogenesis of HIV and the Lung. Curr HIV/AIDS Rep 10, 42–50 (2013). https://doi.org/10.1007/s11904-012-0140-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-012-0140-x

Keywords

Navigation